<!doctype html>
<html>

<head>
    <meta charset="utf-8">
    <title>PDF Template</title>
    <style>
        @font-face {
            font-family: 'HelveticaNeueLTPro-Bd';
            src: url('/css/fonts/HelveticaNeueLTPro-Bd.otf');
        }

        @font-face {
            font-family: 'HelveticaNeueLTPro-BdCn';
            src: url('/css/fonts/HelveticaNeueLTPro-BdCn.otf');
        }

        @font-face {
            font-family: 'HelveticaNeueLTPro-BdIt';
            src: url('/css/fonts/HelveticaNeueLTPro-BdIt.otf');
        }

        @font-face {
            font-family: 'HelveticaNeueLTPro-Lt';
            src: url('/css/fonts/HelveticaNeueLTPro-Lt.otf');
        }

        @font-face {
            font-family: 'HelveticaNeueLTPro-Md';
            src: url('/css/fonts/HelveticaNeueLTPro-Md.otf');
        }

        @font-face {
            font-family: 'HelveticaNeueLTPro-MdCn';
            src: url('/css/fonts/HelveticaNeueLTPro-MdCn.otf');
        }

        @font-face {
            font-family: 'HelveticaNeueLTPro-Roman';
            src: url('/css/fonts/HelveticaNeueLTPro-Roman.otf');
        }

        body {
            font-family: 'HelveticaNeueLTPro-Md';
            font-size: 12px;
            margin: 0px;
            padding: 0px;
            width: 100%;
            float: left;
            background: #ccc;
            height: 100%;
        }

        p {
            margin: 0px;
            padding: 0px;
        }

        .container {
            width: 770px;
            margin: 0px auto;
            height: 1090px;
            overflow: hidden;
            background: #fff;
        }

        .mid_container {
            padding: 25px 75px 5px;
            width: 620px;
            margin: 0px auto;
            height: auto;
            overflow: hidden;
        }

        .header {
            float: left;
            width: 100%;
            margin-bottom: 5px;
        }

        .title {
            float: right;
        }

        .title p {
            font-size: 8pt;
            font-family: 'HelveticaNeueLTPro-Roman';
            color: #000000;
            line-height: 16px;
            width: 170px;
        }

        .title p span {
            font-size: 8.19pt;
            color: #ac0772;
        }

        .message {
            float: left;
            width: 100%;
            margin-bottom: 10px;
        }

        .message p {
            float: left;
            width: 100%;
            color: #005cab;
            font-size: 15pt;
            line-height: 28px;
            padding: 0px;
            letter-spacing: -0.4px;
            font-family: bold
        }

        .message p span {
            color: #ac0772;
        }

        .table_heading {
            font-size: 11pt;
            color: #000000;
            font-family: 'HelveticaNeueLTPro-Bd';
        }

        .datagrid table {
            border-collapse: collapse;
            text-align: left;
            width: 100%;
        }

        .datagrid {
            background: #fff;
            overflow: hidden;
            border: 1px solid #005cab;
        }

        .datagrid table th {
            padding: 10px 15px;
            text-align: left;
            font-size: 11pt;
            color: #fff;
        }

        .datagrid table td {
            padding: 5px 15px;
            text-align: left;
            font-size: 10.32pt;
        }

        .datagrid table thead th {
            background: #005cab;
            font-family: 'HelveticaNeueLTPro-Md';
            color: #fff;
            font-size: 11pt;
            border-left: 1px solid #005cab;
        }

        .datagrid table thead th:first-child {
            border: none;
        }

        .datagrid table tbody td {
            font-family: 'HelveticaNeueLTPro-Md';
            color: #000000;
            font-size: 9pt;
            border-bottom: 1px solid #005cab;
            border-right: 1px solid #005cab;
            font-weight: normal;
        }

        .datagrid table tbody td:last-child {
            border-right: none;
        }

        .datagrid table tbody .alt td {
            background: #E1EEF4;
            color: #00496B;
        }

        .datagrid table tbody td:first-child {
            border-left: none;
        }

        .datagrid table tbody tr:last-child td {
            border-bottom: none;
        }

        .datagrid table tfoot td div {
            border-top: 1px solid #006699;
            background: #E1EEF4;
        }

        .datagrid table tfoot td {
            padding: 0;
            font-size: 12px;
        }

        .datagrid table tfoot td div {
            padding: 2px;
        }

        .datagrid table tfoot td ul {
            margin: 0;
            padding: 0;
            list-style: none;
            text-align: right;
        }

        p.inclusion_head {
            font-size: 11pt;
            color: #140f06;
        }

        p.inclusion_body {
            font-size: 9pt;
            color: #000000;
        }

        .warning_content {
            border: 1px solid #000;
            float: left;
            margin: 5px 0px;
            width: 100%;
        }

        .warning_content h4 {
            color: #000000;
            font-size: 10.5pt;
            text-align: left;
            margin: 5px 10px;
        }

        .warning_content h5 {
            color: #000000;
            font-size: 9.5pt;
            font-weight: bold;
            text-align: left;
            font-weight: bold;
            margin-left: 15px;
            text-decoration: underline;
            margin-bottom: 0px;
            margin-top: 0px;
        }

        .warning_content ul {
            margin-top: 5px;
            margin-bottom: 10px;
            float: left;
        }

        .warning_content ul li {
            font-size: 9.5pt;
            line-height: 14px;
            list-style: none;
            margin-left: -25px;
            width: 100%;
            float: left;
        }

        .warning_content ul li span {
            font-size: 9.5pt;
            line-height: 14px;
            list-style: none;
        }

        .content {
            width: 100%;
            float: left;
            margin-bottom: 25px;
        }

        .content .pls_read {
            color: #000000;
            float: left;
            width: 100%;
            font-size: 9pt;
        }

        .content .pls_read_body {
            color: #140f06;
            float: left;
            width: 100%;
            font-size: 8pt;
        }

        .footer {
            width: 100%;
            float: left;
        }

        .footer p.copyright {
            font-size: 7.5pt;
            color: #000000;
            line-height: 30px;
            float: left;
        }

    </style>
</head>

<body>
    <div class="container">
        <!-- Container Start -->
        <!-- mid-container Start -->
        <div class="mid_container">
            <!-- Header Start -->
            <div class="header">

                <img src="/img/logo_OxiConton.png" alt="Logo" title="Logo" width="180" style="margin-left:225px; margin-top:25px;" />
                <div class="title">
                    <p>[This formulary information <br>is prepared for [physician/medical<br> group practice].]</p>
                </div>

            </div>
            <!-- Header End -->
            <!-- Message Start -->
            <div class="message">
                <p>[PERCENT]i [PATIENTS] in your area have unrestricted access to OxyContinÂ® and pay [CO-PAY THRESHOLD]ii or
                    less.
                </p>
            </div>
            <!-- Message End -->
            <!-- Table Start -->
            <p class="table_heading">This includes patients enrolled in the following:</p>
            <div class="datagrid">
                <table>
                    <thead>
                        <tr>
                            <th>Channel</th>
                            <th>Plan Name</th>
                            <th>Formulary Status</th>
                        </tr>
                    </thead>

                    <tbody>
                        <tr>
                            <td>[Channel]</td>
                            <td>[Plan Name]</td>
                            <td>[Formulary Status]</td>
                        </tr>
                        <tr>
                            <td>[Channel]</td>
                            <td>[Plan Name]</td>
                            <td>[Formulary Status]</td>
                        </tr>
                        <tr>
                            <td>[Channel]</td>
                            <td>[Plan Name]</td>
                            <td>[Formulary Status]</td>
                        </tr>
                        <tr>
                            <td>[Channel]</td>
                            <td>[Plan Name]</td>
                            <td>[Formulary Status]</td>
                        </tr>
                        <tr>
                            <td>[Channel]</td>
                            <td>[Plan Name]</td>
                            <td>[Formulary Status]</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <!-- Table End -->

            <p class="inclusion_head">Inclusion on formulary does not imply superior clinical efficacy or safety.</p>
            <p class="inclusion_body">Please note that formularies are subject to change. Please check with the health plan directly to confirm coverage
                for individual patients. Patient costs may vary among plans.</p>
            <p class="inclusion_body">Preferred represents available on formulary at the lowest branded co-pay. PDL represents on the Preferred Drug
                List.
            </p>
            <p class="inclusion_body">i. Computed as patient prescriptions that can be filled with no prior authorization or step edits for ButransÂ®
                divided by the total prescriptions filled in the area over a three month period.</p>
            <p class="inclusion_body">ii. Only plans with average co-pays for ButransÂ® that are [CO-PAY THRESHOLD] or less are displayed. The plansâ
                co-pay ranges represent the 25th percentile cost up to the 75th percentile cost. Some patients may experience
                co-pays higher than reflected in the message.</p>

            <!-- Warning Box Start -->
            <div class="warning_content">
                <h4>WARNING: ADDICTION, ABUSE and MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL EXPOSURE; NEONATAL
                    OPIOID WITHDRAWAL SYNDROME; and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS
                </h4>

                <div style="width:50%; float:left;">
                    <h5>Addiction, Abuse, and Misuse</h5>
                    <ul>
                        <li>ButransÂ® exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which
                            can lead to overdose and death. Assess each patientâs risk prior to prescribing Butrans, and
                            monitor all patients regularly for the development of these behaviors and conditions <span>[see Warnings and Precautions (5.1) and Overdosage (10)].</span>                            </li>
                        <li>CAMBIAÂ® is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.</li>
                    </ul>
                    <h5>Addiction, Abuse, and Misuse</h5>
                    <ul>
                        <li>ButransÂ® exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which
                            can lead to overdose and death. Assess each patientâs risk prior to prescribing Butrans, and
                            monitor all patients regularly for the development of these behaviors and conditions <span> [see Warnings and Precautions (5.1) and Overdosage (10)].</span>                            </li>
                        <li>CAMBIAÂ® is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.</li>
                    </ul>
                </div>

                <div style="width:50%; float:right;">
                    <h5>Addiction, Abuse, and Misuse</h5>
                    <ul>
                        <li>ButransÂ® exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which
                            can lead to overdose and death. Assess each patientâs risk prior to prescribing Butrans, and
                            monitor all patients regularly for the development of these behaviors and conditions <span>[see Warnings and Precautions (5.1) and Overdosage (10)].</span>                            </li>
                        <li>CAMBIAÂ® is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.</li>
                    </ul>
                    <h5>Addiction, Abuse, and Misuse</h5>
                    <ul>
                        <li>ButransÂ® exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which
                            can lead to overdose and death. Assess each patientâs risk prior to prescribing Butrans, and
                            monitor all patients regularly for the development of these behaviors and conditions <span> [see Warnings and Precautions (5.1) and Overdosage (10)].</span>                            </li>
                        <li>CAMBIAÂ® is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.</li>
                    </ul>
                </div>
            </div>
            <!-- Warning Box End -->
            <!-- Content Start -->
            <div class="content">
                <p class="pls_read">Please read accompanying Full Prescribing Information, including Boxed Warning above.</p>
                <p class="pls_read_body">SOURCE: All prescriptions data from IMS Health XponentTM PlanTrakTM; Commercial and Medicaid co-pay data
                    calculated from IMS Health Formulary Impact AnalyzerTM; Medicare co-pay data calculated from CMS. Formulary
                    data from Managed Markets Insight & Technology, LLC, database as of [Month Year].</p>

            </div>
            <!-- Content Start -->

            <div class="footer">
                <img src="/img/logo_footer.png" title="Purdue Logo" width="60" style="float:left; margin-right:15px;" />
                <p class="copyright">Â©2017 Purdue Pharma L.P., Stamford, CT 06901-3431</p>

                <div style="float:right;width:200px; line-height: 30px;">
                    <p style=" font-size:10pt;color:#005cab; float:left;">www.OxyContin.com</p>
                    <p style="font-family:arial; color:#000000; font-size:8pt; margin-left:15pt; float:right;">MR-01486</p>
                </div>
            </div>
        </div>
        <!-- mid-container Start -->
        <!-- Footer End -->

    </div>
    <!-- Container End -->
</body>

</html>
